Page 61 - 2013FallSale

This is a SEO version of 2013FallSale. Click here to view full version

« Previous Page Table of Contents Next Page »
Page 61
The Willner Window Product Reference Catalog, Autumn, 2013
since 1911
• Willner Chemists •
the nutritional supplement professionals
NOW Foods
*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
SCIENCE DELIVERS
NOW
®
Foods’ new Pterostilbene & Resveratrol Veg Caps combine 50 mg pTeroPure
®
trans-Pterostilbene with 250 mg trans-Resveratrol per capsule to create the industry’s
highest potency combination of these two powerful phytochemicals. Like Resveratrol,
Pterostilbene is a polyphenol, but animal studies have shown that Pterostilbene has better
oral bioavailability, superior biological activity, and is metabolized at a slower rate than
Resveratrol. Emerging research indicates that Pterostilbene offers outstanding
cardiovascular support bene ts as well.*
Anti-Aging Power
Superior Biological Activity*
www.nowfoods.com
In a prospective, randomized, double-blind, placebo-controlled clinical trial with 80 subjects (average
age 54 years), supplementation with trans-Pterostilbene (pTeroPure
®
) resulted in statistically
significant support of systolic and diastolic blood pressure already within the normal range.
1
• Anti-Aging*
• Supports Cardiovascular Health*
• Combines Two Powerful Free Radical-Scavenging Polyphenols*
• Promotes a Healthy Response to Cellular Stress*
• Superior Biological Activity & Oral Bioavailability*
• Supports Blood Pressure Already in the Normal Range*
0
-3.67
-7.77
#
-2.23
-7.32
##
-1
-2
-3
-4
-5
-6
-7
-8
-9
Change in Systolic
Blood Pressure, mmHg
Change in Diastolic
Blood Pressure, mmHg
Pterostilbene
50 mg twice a day
Pterostilbene
125 mg twice a day
1
Riche DM, et al. American Heart Association 2012 Scienti c Sessions on Blood
Pressure Research., Washington, D.C., Sept 19-22 2012.
E ect of two doses of
pterostilbene
supplementation for
6-8 weeks on mean
systolic and diastolic
blood pressure
measurements in
adults (#p=0.005,
##p=0.001 as
compared to placebo).